A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics for a Single Dose of HRS-9821 Powder for Inhalation and Inhalation Suspension Administered in Healthy Subjects and Multiple Doses in Patients With COPD.
Clinical trial NCT07116915 · RECRUITING
Trial details
- NCT number
- NCT07116915
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-11
- Primary completion
- 2026-12-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.